ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,336,878 | -78.0% | 464,450 | -75.1% | 0.02% | -79.5% |
| Q2 2023 | $37,913,002 | +8223.8% | 1,866,716 | +8375.4% | 0.08% | +8200.0% |
| Q4 2022 | $455,477 | -95.6% | 22,025 | -94.6% | 0.00% | -97.1% |
| Q2 2022 | $10,341,000 | +70.6% | 408,122 | +172.6% | 0.03% | +61.9% |
| Q4 2021 | $6,060,000 | +167.9% | 149,730 | +130.8% | 0.02% | +133.3% |
| Q3 2021 | $2,262,000 | +23.6% | 64,873 | -2.7% | 0.01% | 0.0% |
| Q2 2021 | $1,830,000 | -77.1% | 66,647 | -76.6% | 0.01% | -76.9% |
| Q1 2021 | $7,989,000 | +477.2% | 284,526 | +433.6% | 0.04% | +387.5% |
| Q4 2020 | $1,384,000 | -34.3% | 53,321 | -64.8% | 0.01% | -68.0% |
| Q1 2020 | $2,105,000 | – | 151,677 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |